MaryTCasertaMD
Pediatric Infectious Disease • Rochester, NYProfessor, Pediatrics, University of Rochester School of Medicine & Dentistry
Dr. Caserta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 635
Rochester, NY 14642Phone+1 585-275-7787
Education & Training
University of Rochester Medical CenterFellowship, Pediatric Infectious Diseases, 1988 - 1991
Children's Hospital of PhiladelphiaResidency, Pediatrics, 1986 - 1987- Childrens Hospital of PhiladelphiaInternship, Transitional Year, 1984 - 1985
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1984
Certifications & Licensure
NY State Medical License 1987 - 2027
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease) Start of enrollment: 2016 Jan 01
- Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss Start of enrollment: 2015 Feb 24
- Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Association of disease severity and genetic variation during primary Respiratory Syncytial Virus infections.William Bender, Yun Zhang, Anthony Corbett, Chinyi Chu, Alexander Grier
BMC Medical Genomics. 2024-06-19 - 7 citationsOral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Tr...David W Kimberlin, Inmaculada Aban, Kalyani Peri, Javier K Nishikawa, Jolanta Bernatoniene
The Journal of Pediatrics. 2024-05-01 - 27 citationsPalivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection.Mary T Caserta, Sean T O'Leary, Flor M Munoz, Shawn L Ralston,
Pediatrics. 2023-07-01
Press Mentions
- Moderna’s RSV Vaccine for Older Adults Joins Race for First ApprovalJanuary 18th, 2023
- URMC Part of RSV Vaccine Trials for Youngest ChildrenDecember 1st, 2022
- Here's What to Know About RSV This Holiday SeasonNovember 28th, 2022
- Join now to see all
Grant Support
- Child Stress And Resilience: Immune/Virologic OutcomesEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2012
- Child Stress And Resilience: Immune/Virologic OutcomesNational Center For Research Resources2004–2005
- Child Stress And Resilience--Immune/Virologic OutcomesEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
